While it is known that empagliflozin plays a vital role in reducing cardiovascular death (CVD) or...
Author - Hippocrates Briefs Team
ARNI vs. ACEi In Reducing Heart Failure Events Post-Myocardial...
Angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) are drugs...
AHA Construct of Cardiovascular Health: Life’s Essential 8
The American Heart Association (AHA) worked on cardiovascular health, and in 2010 they defined a...
ACC Guidelines for Maternal Cardiovascular Care
The main purpose of the American College of Cardiology (ACC) is to change and recover the maternal...
Epidemiology of Myocarditis and Pericarditis Following mRNA...
Multiple countries have observed an association between myocarditis or pericarditis and COVID-19...
Polypill for Prevention of Cardiovascular Diseases with Focus on...
The onset of increased levels of liver enzymes or non-alcoholic steatohepatitis has a greater risk...
Aspirin Use to Prevent Cardiovascular Disease: US Preventive...
More than one in four deaths in the US are caused by cardiovascular disease (CVD), which is the...
Single versus multiple arterial grafting in diabetic patients at...
Diabetic patients and multivessel coronary artery disease patients have shown that coronary artery...
Full Guide to a Cardiologist Salary by Subspecialty and Region
There are over 33,000 practicing cardiologists based in the United States. Variations in the...
Using Macavamten for Obstructive HCM: An FDA Update
The EXPLORER-HCM long-term extension study, which demonstrated that using mavacamten to cure...